<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910926-0091</DOCNO><DOCID>910926-0091.</DOCID><HL>   Technology:   Shutdown of Unit   Of Pharmaceutical   Resources Is Slated</HL><DATE>09/26/91</DATE><SO>WALL STREET JOURNAL (J), PAGE C6</SO><CO>   PRX</CO><MS>CONSUMER NON-CYCLICAL (NCY)</MS><IN>DRUG MANUFACTURERS (DRG)TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)</IN><NS>EARNINGS PROJECTIONS (ERP)ACQUISITIONS andamp; MERGERS, TAKEOVERS, BOARD BATTLES (TNM)</NS><RE>NORTH AMERICA (NME)NEW YORK (NY)UNITED STATES (US)CANADA (CN)</RE><LP>   SPRING VALLEY, N.Y. -- Pharmaceutical Resources Inc. saidit was discontinuing manufacturing operations of its QuadPharmaceuticals unit, a troubled generic drug maker.   The company said the shutdown will result in a $13 millioncharge against its earnings for its fourth quarter endingSaturday. The company said it expected an operating lossbefore the charge. In last year's fourth quarter, the companyposted a loss of $3.9 million on sales of $7 million. For thefirst nine months of the current fiscal year, the company hadlosses of $13.1 million on sales of $27.7 million.</LP><TEXT>   Pharmaceutical Resources also said it is seeking a buyerfor all or part of Quad or its assets, which would includemanufacturing facilities and product licenses. But thecompany declined to put a value on Quad's operations.   Kenneth Sawyer, president and chief executive officer ofPharmaceutical Resources, said the company is shutting downQuad, which makes generic injectable drugs, because &quot;the timeand financial commitment required to rehabilitate Quad wouldbe too great for us.&quot;   Pharmaceutical Resources recently was formed as a holdingcompany for Par Pharmaceuticals, a maker of solid oral dosageforms of generic drugs, and its Quad unit. In January 1990,Par and Quad were fined for illegal payments made by twoformer officers to a Food and Drug Administration official,and Quad has been barred from doing business with the federalgovernment until Aug. 31, 1992.</TEXT></DOC>